My Account Log in

1 option

Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation / edited by Azin Alizadehasl, Ardeshir Ghavamzadeh, Amir Hossein Emami, Ghasem Janbabaei, Davood Khoda-Amorzideh.

Springer Medicine eBooks 2024 Available online

View online
Format:
Book
Contributor:
Alizadehasl, Azin, editor.
Language:
English
Subjects (All):
Cardiology.
Cancer--Genetic aspects.
Cancer.
Cancer Genetics and Genomics.
Local Subjects:
Cardiology.
Cancer Genetics and Genomics.
Physical Description:
1 online resource (289 pages)
Edition:
1st ed. 2024.
Place of Publication:
Cham : Springer Nature Switzerland : Imprint: Springer, 2024.
Summary:
This book discusses the epidemiology and the known cardiotoxic effects of chemoradiation agents in addition to newer therapies in hematopoietic stem cell transplantation (HSCT). Recent expert consensus statements from cardiology and hematology/oncology societies are reviewed in regard to risk stratification of the patient based on the type of treatments they are undergoing. Finally, gaps in knowledge are identified with proposed avenues of research that allow for more accurate risk assessment, prediction and potential treatment of the HSCT patient in attenuating the risk of developing cardiovascular comorbidities. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation reveals a picture of effective management of these patients in order to optimize both short- and long-term outcomes of HSCT. It is of considerable interest to all involved or training within this rapidly growing area of cardiology and oncology.
Contents:
HSCT at a glance
Burden of cardiovascular disease in HSCT
Risk factors and Mechanisms of Cardiotoxicity in HSCT
Cardiotoxicity of commonly used drugs in HSCT
Pre-HSCT cardiovascular evaluation
HSCT in low EF patients
Arrhythmias and conduction disorders in HSCT
Coronary and peripheral arterial disease in HSCT
Thrombotic disease in HSCT
Pulmonary hypertension in HSCT
Pericardial disease in HSCT
Metabolic syndrome in HSCT
HSCT in patients with cardiac amyloidosis
HSCT in patients with autoimmune conditions, sickle cell anaemia and thalassemia
Cardiotoxicity surveillance and cardioprotective strategies in HSCT.
Notes:
Includes bibliographical references and index.
ISBN:
3-031-53659-2

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account